摘要： 2025年度，日联科技实现营业收入10.71亿元，同比增长44.88%；实现归属于母公司所有者的 净利润1.75亿元，同比增长21.81%。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我 们的推送。 日联科技集团股份有限公司（以下简称"日联科技"）近日发布2 0 2 5年度业绩快报。报告显示， 公司在过去一年中经营业绩实现显著增长，高质量发展态势明显。 公告数据显示，2 0 2 5年度，日联科技实现营业收入 1 0 . 7 1亿元 ，同比增长 4 4 . 8 8% ；实现归 属于母公司所有者的净利润 1 . 7 5亿元 ，同比增长 2 1 . 8 1% ；实现归属于母公司所有者的扣除 非经常性损益的净利润 1 . 4 5亿 元 ，同比大幅增长 5 0 . 8 5% ，显示出公司主营业务的强劲盈利 能力。 从财务健康状况来看，截至报告期末，公司总资产达到 4 1 . 0 8亿元 ，较报告期初增长 1 2 . 8 8% ；归属于母公司的所有者权益为 3 3 . 6 9亿元 ， 较报告期初增长 4 . 2 8% 。尤为值得关注的是， 公司经营活动 ...

点击注册小程序 查看完整报告 特别申明： 本订阅号中所涉及的证券研究信息由光大证券研究所编写，仅面向光大证券专业投资者客户，用作新媒体形势下研究 信息和研究观点的沟通交流。非光大证券专业投资者客户，请勿订阅、接收或使用本订阅号中的任何信息。本订阅号 难以设置访问权限，若给您造成不便，敬请谅解。光大证券研究所不会因关注、收到或阅读本订阅号推送内容而视相 关人员为光大证券的客户。 控股子公司设立后： 报告摘要 事件： 日联科技发布2025年业绩快报。2025年，公司实现营业总收入/归母净利润/扣非净利润分别为10.7/1.7/1.5 亿元，同比+45%/+22%/+51%。 点评： 25年新签订单同比大幅增长，射线源实现大规模出货 2025年，公司工业X射线源实现全谱系覆盖，微焦点射线源实现大规模出货，纳米级开管射线源以及大功 率射线源顺利实现产业化，AI智能检测软件、3D/CT检测技术等领域实现突破，产品市场竞争力得到提 升，新签订单实现大幅度增长。公司践行下游多应用领域布局战略，产品已全面覆盖集成电路及电子制 造、新能源电池、铸件焊件及材料检测等战略新兴领域，并积极把握下游领域的产业发展机遇，不断开拓 新应用 ...

Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected price increase of over 15% in the next 6-12 months [3][11]. Core Insights - The company is projected to achieve a revenue of 1.071 billion RMB in 2025, representing a year-on-year growth of 44.9%. The net profit attributable to shareholders is expected to reach 175 million RMB, with a growth of 21.8% [1][3]. - The significant profit growth is attributed to a focus on core business areas, increased R&D investment, and the successful industrialization of advanced technologies and products, enhancing market competitiveness [2]. - The company has successfully executed several major acquisitions, including a 55% stake in Zhuhai Jiuyuan, entering the battery performance testing sector, and a 66% stake in Singapore's SSTI, which allows entry into semiconductor testing and failure analysis [2]. Financial Projections - The forecasted net profits for the company are 170 million RMB for 2025, 330 million RMB for 2026, and 460 million RMB for 2027, with respective growth rates of 21.8%, 87.6%, and 39.7% [3][8]. - The projected P/E ratios for 2025, 2026, and 2027 are 63x, 37x, and 27x, respectively [3]. Revenue and Profit Growth - The company’s revenue is expected to grow from 587 million RMB in 2023 to 2.356 billion RMB in 2027, with growth rates of 21.19%, 25.89%, 44.88%, 57.77%, and 39.39% for the respective years [8][10]. - The net profit is projected to increase from 114 million RMB in 2023 to 457 million RMB in 2027, with growth rates of 59.27%, 25.44%, and subsequent years showing significant increases [8][10].

Financial Performance - In 2025, the company achieved operating revenue of 1,071.37 million RMB, an increase of 44.88% year-on-year [2] - The net profit attributable to the parent company was 174.57 million RMB, up 21.81% year-on-year [2] - The net profit attributable to the parent company after deducting non-recurring gains and losses was 145.08 million RMB, reflecting a 50.85% increase year-on-year [2] - Total assets at the end of the reporting period were 4,107.71 million RMB, a 12.88% increase from the beginning of the period [2] - Shareholders' equity attributable to the parent company was 3,368.57 million RMB, up 4.28% from the beginning of the period [2] - Net cash flow from operating activities was 191.46 million RMB, a significant increase of 509.37% year-on-year [2] Business Strategy and Development - The company focused on its core business and increased R&D investment, enhancing its core technology and product autonomy [2] - The company achieved full-spectrum coverage in industrial X-ray sources and large-scale shipments of micro-focus X-ray sources [2] - New orders saw significant growth due to the company's strategic layout in multiple downstream application fields, including integrated circuits, electronic manufacturing, and new energy batteries [2] - The company is actively expanding its global presence and enhancing its core capabilities in product strength, channel strength, and brand strength [2] Investment and Subsidiary Establishment - The company plans to establish a holding subsidiary, Saimikang Semiconductor (Wuxi) Co., Ltd., with an investment of 7.7 million RMB from its own funds and 3.3 million RMB from its subsidiary [6] - The holding subsidiary aims to enhance the company's business layout in high-end semiconductor testing equipment and strengthen its supply capabilities [8] - The establishment of the subsidiary is expected to improve the company's product line in semiconductor failure analysis and defect detection [12] - The investment will not significantly impact the company's financial status or operating results for the current year [14]

Core Viewpoint - The company, Riheng Technology Group Co., Ltd., is voluntarily disclosing its investment to establish a holding subsidiary, aiming to enhance its capabilities in the high-end semiconductor testing equipment sector and to localize production in China [2][4]. Group 1: Investment Overview - The investment target is Semicon (Wuxi) Co., Ltd., with an investment amount of 7.7 million yuan from Riheng Technology and 3.3 million yuan from its subsidiary SSTI [2]. - The holding subsidiary will have a registered capital of 11 million yuan, with Riheng Technology holding 70% and SSTI holding 30% [4]. - This investment does not constitute a related party transaction or a major asset restructuring as defined by relevant regulations [2][5]. Group 2: Impact of Investment - The investment will facilitate deep collaboration between Riheng Technology and SSTI in semiconductor testing technology, enhancing the company's technological capabilities and product offerings [7]. - The establishment of the subsidiary will extend the company's product line into critical areas such as semiconductor design debugging and yield improvement, positioning it as a one-stop solution provider in the semiconductor testing market [7]. - The investment is expected to improve the company's market competitiveness by leveraging domestic resources and established customer networks, aiming to capture a larger share of the high-end semiconductor testing market in China [7]. Group 3: Financial Impact - The investment will change the scope of the company's consolidated financial statements, with the new subsidiary being included in the consolidated reports [8]. - The funding for this investment will come from the company's own funds, and it is anticipated that this will not have a significant impact on the company's financial status or operating results for the current year [8].

Core Viewpoint - The company reported a significant increase in revenue and net profit for the fiscal year 2025, indicating strong business performance and growth potential in its core areas [1] Financial Performance - The company achieved an operating revenue of 1.071 billion yuan, representing a year-on-year increase of 44.88% [1] - The net profit attributable to the parent company was 175 million yuan, reflecting a year-on-year growth of 21.81% [1] Business Strategy and Development - The company focused on its core business and increased R&D investment to strengthen its position in core technologies and products [1] - The company achieved full-spectrum coverage in industrial X-ray sources and large-scale shipments of micro-focus X-ray sources, along with successful industrialization of nano-level open-tube X-ray sources and high-power X-ray sources [1] - Breakthroughs were made in AI intelligent detection software and 3D/CT detection technology, enhancing product market competitiveness [1] Market Expansion and Applications - The company has implemented a strategy to expand into multiple downstream application fields, with products covering integrated circuits, electronic manufacturing, new energy batteries, and material testing [1] - The company actively seizes industrial development opportunities in downstream sectors and continuously explores new application scenarios to consolidate its market leadership [1] Globalization Efforts - The company is advancing its global layout by promoting domestic and international R&D production capabilities and marketing network construction [1] - Core competencies such as product strength, channel strength, and brand strength are continuously enhanced, leading to an overall improvement in comprehensive competitiveness [1]

格隆汇2月27日丨日联科技(688531.SH)公布2025年度业绩快报，报告期内，公司实现营业收入10.71亿 元，同比增加44.88%；实现归属于母公司所有者的净利润1.75亿元，同比增加21.81%；实现归属于母公 司所有者的扣除非经常性损益的净利润1.45亿元，同比增加50.85%。 报告期末，公司财务状况良好，总资产41.08亿元，较报告期初增加12.88%；归属于母公司的所有者权 益33.69亿元，较报告期初增加4.28%；经营活动产生的现金流量净额为1.91亿元，同比增长509.37%。 报告期内，公司始终专注主业，持续加大研发投入，巩固核心技术及产品自主可控地位。公司工业X射 线源实现全谱系覆盖，微焦点射线源实现大规模出货，纳米级开管射线源以及大功率射线源顺利实现产 业化，AI智能检测软件、3D/CT检测技术等领域实现突破，产品市场竞争力得到提升，新签订单实现大 幅度增长；公司坚定践行下游多应用领域布局战略，产品已全面覆盖集成电路及电子制造、新能源电 池、铸件焊件及材料检测等战略新兴领域，并积极把握下游领域的产业发展机遇，不断开拓新应用场 景，进一步巩固市场领先地位；此外，公司持续开展全球化布 ...